Champions Oncology (CSBR) Other financing activities (2015)

Champions Oncology (CSBR) recorded quarterly Other financing activities of $18000.0 in Q3 2015.

Champions Oncology (CSBR) Other financing activities (2015) Analysis & Trends

Champions Oncology's Other financing activities history runs 1 years deep, the most recent figure standing at $18000.0 for Q3 2015.

In Q3 2015, Other financing activities changed N/A year-over-year to $18000.0; the TTM figure through Apr 2016 stood at $18000.0 (changed N/A YoY), while the FY2016 annual figure was $18000.0, changed N/A from the prior year.
Other financing activities was $18000.0 for Q3 2015 at Champions Oncology.
In the past five years, Other financing activities ranged from a high of $18000.0 in Q3 2015 to a low of $18000.0 in Q3 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn
9	Abivax	94.37 Bn	94.37 Bn	-
10	Champions Oncology	78.46 Mn	71.46 Mn	13.89 Mn

Historic Data

Download Data

Date	Value
Jul 31, 2015	18,000.00
Jul 31, 2015	18,000.00